4791 TREATMENT WITH PCSK9 INHIBITORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT VERY HIGH CARDIOVASCULAR RISK

• Published in: Nephrology, dialysis, transplantation Vol. 38; no. Supplement_1
• Main Authors: Amaro, Jose Manuel, Fernández, Florentino Villanego, Muñoz, Javier Naranjo, Orellana, Cristhian, Sánchez, Luis Alberto Vigara, López, Juan Manuel Cazorla, Mejía, Carlos Narváez, Alonso, Marta, Aguilera, Aurora, Blanca, María Auxiliadora Mazuecos
• Format: Journal Article
• Language: English
• Published: 14.06.2023

Abstract Background and Aims Proprotein convertase subtilisin/kexin type 9 (iPCSK9) inhibitors may be an option in the treatment of dyslipidaemia in patients with chronic kidney disease (CKD) who do not reach therapeutic targets or who do not tolerate statins at maximal doses. However, studies in th...